Acadia Healthcare (NASDAQ:ACHC – Get Free Report) had its price objective lowered by investment analysts at Barclays from $20.00 to $17.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Barclays‘s price objective indicates a potential downside of 9.91% from the stock’s current price.
ACHC has been the topic of several other reports. Mizuho decreased their target price on shares of Acadia Healthcare from $32.00 to $22.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 13th. KeyCorp lowered their price objective on Acadia Healthcare from $55.00 to $35.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 8th. Guggenheim cut their target price on shares of Acadia Healthcare from $36.00 to $29.00 and set a “buy” rating for the company in a research report on Thursday, August 7th. Bank of America downgraded shares of Acadia Healthcare from a “buy” rating to a “neutral” rating and dropped their price objective for the stock from $27.00 to $25.00 in a report on Wednesday, September 10th. Finally, UBS Group decreased their target price on Acadia Healthcare from $45.00 to $31.00 and set a “buy” rating on the stock in a report on Thursday, August 7th. Eight equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $34.82.
Get Our Latest Stock Report on ACHC
Acadia Healthcare Trading Down 8.7%
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last posted its earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.71 by $0.01. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The firm had revenue of $851.57 million for the quarter, compared to the consensus estimate of $852.43 million. During the same quarter in the prior year, the business posted $0.91 earnings per share. The business’s quarterly revenue was up 4.4% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. Equities research analysts anticipate that Acadia Healthcare will post 3.38 EPS for the current year.
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in the business. Verdence Capital Advisors LLC increased its position in shares of Acadia Healthcare by 3.3% during the 2nd quarter. Verdence Capital Advisors LLC now owns 14,656 shares of the company’s stock valued at $333,000 after purchasing an additional 465 shares during the period. EverSource Wealth Advisors LLC raised its stake in Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after acquiring an additional 497 shares in the last quarter. PNC Financial Services Group Inc. grew its holdings in Acadia Healthcare by 10.3% during the 1st quarter. PNC Financial Services Group Inc. now owns 6,672 shares of the company’s stock worth $202,000 after acquiring an additional 622 shares during the last quarter. LPL Financial LLC lifted its stake in shares of Acadia Healthcare by 1.2% during the first quarter. LPL Financial LLC now owns 56,527 shares of the company’s stock valued at $1,651,000 after acquiring an additional 697 shares during the period. Finally, Public Employees Retirement System of Ohio boosted its position in shares of Acadia Healthcare by 2.6% in the 2nd quarter. Public Employees Retirement System of Ohio now owns 30,468 shares of the company’s stock worth $691,000 after purchasing an additional 760 shares during the last quarter.
About Acadia Healthcare
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Articles
- Five stocks we like better than Acadia Healthcare
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- From Dividends to Growth: Why These 3 Stocks Stand Out in 2025
- 5 Top Rated Dividend Stocks to Consider
- AMD’s Price Pullback Equals Opportunity: The Big Gains Are Coming
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Uber Stock Pullback Looks Like a Clear Buying Opportunity
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
